Add Presentation to Slide Tray Presentation:
Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Adverse Events of Interest in Studies of rhGH Treatment of Patients With CF
The adverse events of interest outlined in this slide were determined a priori in the preparation of this CER.
Keywords: CF | CF-related diabetes | CFDR | HGH | biomarker | cancer | cystic fibrosis | human growth hormone | recombinant human growth hormone | rhGH | risk
- Phung OJ, Coleman CI, Baker EL, et al. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis. AHRQ Comparative Effectiveness Review No. 23 (Prepared by University of Connecticut-Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2010. AHRQ Publication No. 11-EHC003-EF.
Your slide tray is being processed.